Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives in narcolepsy research and therapy

E Mignot1

  • 1Sleep Disorders Center, Palo Alto, CA 94301, USA.

Current Opinion in Pulmonary Medicine
|November 1, 1996
PubMed
Summary

Narcolepsy, a disabling sleep disorder, may stem from neuroimmune interactions rather than direct autoimmune processes. Research highlights genetic links and immune system involvement, suggesting new treatment avenues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of the differential response to exercise in adults with restless legs syndrome.

Sleep medicine·2024
Same author

DOSED: A deep learning approach to detect multiple sleep micro-events in EEG signal.

Journal of neuroscience methods·2019
Same author

Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.

International journal of obesity (2005)·2016
Same author

Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study.

Molecular psychiatry·2014
Same author

The structured diagnostic interview for sleep patterns and disorders: rationale and initial evaluation.

Sleep medicine·2014
Same author

HLA-DQ association and allele competition in Chinese narcolepsy.

Tissue antigens·2012

Area of Science:

  • Neuroscience
  • Immunology
  • Sleep Medicine

Background:

  • Narcolepsy with cataplexy is a disabling sleep disorder affecting 0.05% of the population.
  • Hypersomnias without cataplexy are clinically heterogeneous, requiring thorough evaluation.
  • Current treatments for narcolepsy-cataplexy are symptomatic, targeting sleepiness and REM sleep abnormalities.

Purpose of the Study:

  • To explore the etiological underpinnings of narcolepsy, particularly the role of the immune system.
  • To differentiate narcolepsy-cataplexy from other hypersomnias.
  • To investigate potential novel therapeutic targets based on emerging genetic and immunological findings.

Main Methods:

  • Review of genetic research on narcolepsy.
  • Analysis of human and canine narcolepsy genetic associations (e.g., HLA-DQB1*0602).
  • Examination of microglial expression of MHC molecules in canine narcolepsy.

Main Results:

  • Genetic studies implicate the immune system, not monoaminergic or cholinergic systems, as a primary cause of narcolepsy.
  • Human narcolepsy is strongly associated with HLA-DQB1*0602.
  • Canine narcolepsy shows links to immunoglobulin gene segments and increased microglial MHC expression.

Conclusions:

  • Narcolepsy may involve novel neuroimmune interactions rather than a direct autoimmune process.
  • Findings suggest a paradigm shift in understanding narcolepsy etiology.
  • Opens new perspectives for developing targeted treatments for narcolepsy.

Related Experiment Videos